| |
| |
|
| Insider
Information: |
Fuchs Henry J |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
222,228 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,063,061 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
222,228 |
|
|
| Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
294 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-03-15 |
4 |
D |
$92.50 |
$473,230 |
D/D |
(5,116) |
120,402 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,790 |
140,192 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2017-04-01 |
4 |
A |
$31.49 |
$9,982 |
D/D |
317 |
4,608 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-04-28 |
4 |
A |
$70.30 |
$21,232 |
D/D |
302 |
140,494 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-05-15 |
4 |
D |
$91.50 |
$186,294 |
D/D |
(2,036) |
138,458 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-06-02 |
4 |
D |
$90.72 |
$184,706 |
D/D |
(2,036) |
136,422 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-06-16 |
4 |
OE |
$26.49 |
$484,462 |
D/D |
14,397 |
150,819 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-06-16 |
4 |
AS |
$90.00 |
$1,295,730 |
D/D |
(14,397) |
136,422 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-06-19 |
4 |
OE |
$37.46 |
$22,588 |
D/D |
603 |
137,025 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-06-19 |
4 |
AS |
$90.00 |
$54,270 |
D/D |
(603) |
136,422 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2017-07-01 |
4 |
A |
$32.55 |
$9,993 |
D/D |
307 |
4,915 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-09-15 |
4 |
OE |
$26.49 |
$507,050 |
D/D |
15,000 |
151,422 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-09-15 |
4 |
AS |
$90.50 |
$1,357,500 |
D/D |
(15,000) |
136,422 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2017-10-01 |
4 |
A |
$32.09 |
$9,980 |
D/D |
311 |
5,226 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2018-01-01 |
4 |
A |
$34.20 |
$9,986 |
D/D |
292 |
5,518 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-01-02 |
4 |
OE |
$26.49 |
$507,050 |
D/D |
15,000 |
148,976 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-01-02 |
4 |
AS |
$89.23 |
$1,338,401 |
D/D |
(15,000) |
133,976 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,324 |
153,885 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-02-26 |
4/A |
A |
$0.00 |
$0 |
D/D |
20,463 |
154,024 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-03-02 |
4 |
D |
$79.86 |
$205,719 |
D/D |
(2,576) |
151,309 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-03-15 |
4 |
D |
$83.57 |
$406,234 |
D/D |
(4,861) |
146,448 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,040 |
162,488 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-03-22 |
4/A |
D |
$81.36 |
$474,736 |
D/D |
(5,835) |
156,653 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-03-22 |
4 |
D |
$81.36 |
$472,864 |
D/D |
(5,812) |
156,676 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2018-04-01 |
4 |
A |
$31.29 |
$9,982 |
D/D |
319 |
5,837 |
0 |
- |
|
294 Records found
|
|
Page 9 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
